—ED
— • —
$113.56
P/E
20.09
PEG
0.03
FCF Yield
—
Rev Growth YoY
+1085.0% YoY
Gross Margin
4669.4%
Health Score
4/10
D/E Ratio
1.15
Confidence
LOW
Business Snapshot
The ticker and exchange information provided in this payload are blank, which limits full contextual identification. Based on available data, this appears to be a company generating revenue with extraordinary reported growth rates and extremely elevated margin figures. The absence of a market capitalisation figure prevents precise cap-tier classification, though a current share price of $113.56 is confirmed.
Financial Health
**Score: 4/10** The financial picture here contains several anomalies that warrant serious caution. The reported gross margin of 4,669.4% and net margin of 1,195.0% are statistically implausible for any conventional business and suggest either a data normalisation issue, a very unusual accounting structure, or a one-time event distorting the figures — investors should not treat these as representative of underlying operational health...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 4,669.4% and net margin of 1,195.0% are outside any plausible range for a normal operating business, suggesting distorted or non-representative reported figures. - **VALUATION ANOMALY:** EV/EBITDA of 1,866.77x is an extreme outlier that cannot be used as a reliable valuation anchor and signals possible EBITDA near zero or negative. - **LIQUIDITY:** Current ratio of 1.02x means current assets barely cover current liabilities, leaving almost no buffer against short-term financial stress. - **ANALYST CONSENSUS:** Only 11% of analysts rate this stock a Buy, with 44% at Hold and the overall consensus formally rated as Sell — a notably weak level of Wall Street support. - **TECHNICAL DETERIORATION:** A death cross pattern (50-day MA crossing below 200-day MA) is in place, with the MACD also signalling bearish momentum, indicating a deteriorating price trend. ---...